Key result
High-density mapped atypical flutter ablation yields a ~50% 2-year recurrence rate across all etiologies.
Why the study?
Atypical flutter ablation is technically challenging, carries procedural risks, and has shown limited long-term efficacy in prior studies. This study evaluated the acute and long-term efficacy and safety of atypical flutter ablation guided by high-density electroanatomical mapping across contemporary patient populations.
What is the acute and long-term efficacy and safety of atypical flutter ablation guided by high-density electroanatomical mapping across different patient populations (primary disease, post-ablation, post-surgery, and congenital heart disease)?
Observational (n=160)
What is the acute and long-term efficacy and safety of atypical flutter ablation guided by high-density electroanatomical mapping across different patient populations (primary disease, post-ablation, post-surgery, and congenital heart disease)?
Despite high-density electroanatomical mapping enabling acute procedural success in most patients undergoing atypical flutter ablation, the 2-year recurrence rate remains high at approximately 50%, though patients with congenital heart disease experience significantly lower progression to permanent atrial arrhythmia.
High recurrence after atypical flutter ablation warrants caution in expectations; hypothesis-generating for differential outcomes in congenital heart disease.
Introduction Atypical flutter (AFL) ablation is a technically challenging procedure with limited long-term efficacy according to prior studies and not exempt from risks. Purpose The aim of this study was to describe the efficacy, in terms of acute and long-term rhythm management, and safety of AFL ablation guided by high-density electroanatomical mapping in a population of contemporary patients. We aimed also to compare results between different patient populations. Methods From june 2015 to November 2021, all consecutive AFL ablation procedures guided by high-density electroanatomical mapping were included in the study. Patients were classified in 4 groups according to history of atrial catheter ablation, cardiac surgery, congenital heart disease or none of the above (considered as primary disease). Activation and voltage mapping were used to define AFL circuits and substrate. After AFL characterization, radiofrequency lesions were performed to operator’s discretion until AFL termination. Programmed atrial stimulation was repeated to test AFL inducibility, and any sustained induced atrial arrhythmia was ablated. Procedural success was defined as termination of every induced AFL and no-inducibility. A 3-month blanking period was considered. Follow-up included visits with ECG and/or 24h Holter-ECG at 3, 6, 12, 24 months, and from there on according to physician’s discretion. Results 190 AFL procedures in 160 patients were included. Patient and procedural characteristics of the global cohort as well as different patient populations (27% primary, 37.9% post-ablation, 15.3% post-surgery, 20% congenital heart disease (CHD)) can be found in figure 1 (table). Survival free from atrial arrhythmias in pre-specified groups is shown in figure 2 (left). Overall, a 2-year ∼50% recurrence rate was observed, with a tendency to better outcome in patients with congenital heart disease (∼70%), over the rest of the groups, which behaved similarly (p=0.281). Progression to permanent atrial arrhythmia was lower in this subgroup (2.7% vs 23.5%, p=0.028), as shown in figure 2 (right), probably related to higher rhythm control efforts and stricter follow-ups. CONCLUSIONS In the era of high-density electroanatomical mapping, acute procedural success is achievable in the majority of patients, but recurrence rate remains high, with an approximate 50% 2-year recurrence rate except for congenital heart disease patients, which tend to show better survival free from atrial arrhythmias.Figure 1Figure 2
No takes yet. Share an insight, caveat, or question.
Lozano-Granero et al. (2023) conducted an observational in Atypical flutter (AFL) (n=160). Atypical flutter ablation guided by high-density electroanatomical mapping vs. Patient etiology subgroups (primary disease, post-ablation, post-surgery, congenital heart disease) was evaluated on 2-year atrial arrhythmia recurrence and progression to permanent atrial arrhythmia (p=0.281). High-density mapping-guided atypical flutter ablation had a ~50% 2-year recurrence rate overall, with lower progression to permanent arrhythmia in congenital heart disease patients (2.7% vs 23.5%, p=0.028).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: